Variant report
Variant | esv1803616 |
---|---|
Chromosome Location | chr3:94487032-94538580 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:94525826..94528541-chr3:94529089..94531852,2 | K562 | blood: | |
2 | chr3:94525826..94528541-chr3:94529089..94531852,2 | K562 | blood: | |
3 | chr3:94504783..94506940-chr3:94507538..94510163,2 | MCF-7 | breast: | |
4 | chr3:94529128..94531189-chr3:94544772..94547073,2 | MCF-7 | breast: | |
5 | chr3:94504783..94506940-chr3:94507538..94510163,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548244086 | chr3:94491211-94491212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545391590 | chr3:94491215-94491216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565555158 | chr3:94491232-94491233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9841084 | chr3:94491288-94491289 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs370777640 | chr3:94491289-94491290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs59286802 | chr3:94491311-94491312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531111828 | chr3:94491374-94491375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9814299 | chr3:94491398-94491399 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs77921001 | chr3:94491407-94491408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368739820 | chr3:94491466-94491467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139243093 | chr3:94491470-94491471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565562779 | chr3:94491517-94491518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181961970 | chr3:94491559-94491560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187423413 | chr3:94491576-94491577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142439794 | chr3:94491669-94491670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553392948 | chr3:94491677-94491678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557185822 | chr3:94491680-94491681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567430537 | chr3:94491681-94491682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146372883 | chr3:94491697-94491698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188981365 | chr3:94491708-94491709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573188664 | chr3:94491717-94491718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369981262 | chr3:94491721-94491722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571337908 | chr3:94491752-94491753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545361242 | chr3:94491765-94491766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139716151 | chr3:94491768-94491769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575522773 | chr3:94491769-94491770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142904516 | chr3:94491795-94491796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141415085 | chr3:94506209-94506210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548834184 | chr3:94506210-94506211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560663738 | chr3:94506212-94506213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188768605 | chr3:94506233-94506234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527869589 | chr3:94506315-94506316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546756080 | chr3:94506319-94506320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192476765 | chr3:94506321-94506322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6766302 | chr3:94506339-94506340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139645674 | chr3:94506353-94506354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13324772 | chr3:94506382-94506383 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs13314320 | chr3:94506393-94506394 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs6780760 | chr3:94506423-94506424 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs142836779 | chr3:94506440-94506441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182152130 | chr3:94506465-94506466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13324801 | chr3:94506475-94506476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs186753744 | chr3:94506500-94506501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146083909 | chr3:94506514-94506515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577276064 | chr3:94506526-94506527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571502028 | chr3:94506545-94506546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538872613 | chr3:94506588-94506589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373177230 | chr3:94506617-94506618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557549636 | chr3:94506620-94506621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79870811 | chr3:94506624-94506625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:94491200-94491800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
2 | chr3:94506200-94507200 | Enhancers | Fetal Brain Male | brain |
3 | chr3:94510000-94510600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:94529000-94529200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr3:94529600-94530600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr3:94530600-94531000 | Enhancers | HUES48 Cell Line | embryonic stem cell |